drugset / Trial / NCT05341401
Budesonide Multimatrix(MMX) Versus Prednisolone in Management of Mild to Moderate Ulcerative Colitis
RandomizedParallel-groupSingle-blindTreatment
Summary
My study aims to directly compare the efficacy and safety of Budesonide MMX versus Prednisolone in the management of mild to moderate cases of ulcerative colitis.
Timeline
- Start
- 2022-06
- Primary completion
- 2023-06
- Completion
- 2024-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Budesonide MMX | Small molecule | 9 mg | — |
| Comparator | Prednisolone | Other / unclassified | 5 mg | — |